Logo

milestone payments

Genuity Science, Ionis Pharmaceuticals Partner on Antisense Therapy Development

Genuity Science, formerly known as WuXi NextCode, will receive a combination of upfront, development milestone, and product royalty payments under the deal.

Amgen, Adaptive Biotechnologies Expand Partnership on NGS Blood Cancer Monitoring

The partners will use Adaptive's  ClonoSeq assay to assess minimal residual disease in several of Amgen's hematology drug development programs.

Tempus, Genmab Collaborate on Cancer Biomarker Discovery

Tempus is eligible for milestone payments and royalties for any oncology therapeutics Genmab might develop based on their joint research projects.

Interpace Dx Reaches Deal to Restructure Debt

As part of the deal with an institutional investor, Interpace's royalty and milestone obligations will also be terminated. 

Stratos Hits Milestone, Raises $15M from Roche, Fisk Ventures to Complete Series B Financing

Stratos reached its milestone by demonstrating nanopore sequencing with its proprietary expandable nucleotides, called X-NTPs.